Pendahuluan Kanker Payudara

Oleh dr. Sunita

Kanker payudara merujuk pada berbagai jenis keganasan jaringan payudara dengan tipe yang paling sering ditemukan merupakan adenokarsinoma pada sel yang melapisi unit lobuler duktus terminalis payudara.

Kanker payudara merupakan kanker yang paling sering ditemukan dan merupakan penyebab kematian utama akibat kanker pada wanita. Paparan hormon estrogen, riwayat kanker payudara dalam keluarga, adanya mutasi pada beberapa gen tertentu serta faktor risiko demografik seperti indeks massa tubuh dan tinggi badan juga menjadi determinan risiko kanker payudara.

Diagnosis kanker payudara diterapkan dengan pendekatan bertahap yang melibatkan pengenalan gejala dan tanda, pencitraan klinis melalui ultrasonografi (USG) atau mamografi, biopsi, dan diagnosis patologis guna membedakan tumor payudara jinak dengan kanker payudara.

Penatalaksanaan kanker payudara meliputi pembedahan, radioterapi, kemoterapi, terapi target, dan terapi hormonal.[1,2]

Referensi

1. Torre LA, Bray F, Siegel RL, Ferlay J. Global Cancer Statistics , 2012. CA A Cancer J Clin [Internet]. 2015;65(2):87–108. Available from: http://onlinelibrary.wiley.com/doi/10.3322/caac.21262/full

2. van Diest P, Buerger H, Kuijper A, van der Wall E. Breast Carcinogenesis. In: Kuerer H, editor. Kuerer’s Breast Surgical Oncology. New York: McGraw-Hill; 2010. p. 3–152.

3. Hunt KK, Robertson JFR, Bland KI. The Breast. In: Brunicardi F, Andersen D, Billiar T, Dunn D, Hunter J, Matthews J, et al., editors. Schwartz’s Principles of Surgery. 10th ed. New York: McGraw-Hill; 2015. p. 511–54.

4. Piccart MJ, Gathani T, Zardavas D, Azim H, Sotiriou C, Viale G, et al. Cancer of The Breast. In: Kerr D, Haller D, van de Velde C, Baumann M, editors. Oxford Textbook of Oncology. 3rd ed. Oxford: Oxford University Press; 2016. p. 546–75.

5. World Health Organization. Cancer Country Profiles: Indonesia. Cancer Ctry Profiles. 2014;22–3.

6. Asamris, Burmansyah, Tjindarbumi D, Achmad D, Dlildir D, Handojo D, et al. Panduan Penatalaksanaan Kanker Payudara. In: Manuaba IBTW, editor. Jakarta: Sagung Seto; 2010. p. 17–48.

7. Wahidin M, Noviani R, Hermawan S, Andriani V, Ardian A, Djarir H. Population-based cancer registration in indonesia. Asian Pacific J Cancer Prev. 2012;13(4):1709–10.

8. Chen W. Factors that modify breast cancer risk in women [Internet]. UpToDate. 2015 [cited 2017 Jul 31]. Available from: https://www.uptodate.com/contents/factors-that-modify-breast-cancer-risk-in-women-beyond-the-basics?source=search_result&search=breast+cancer&selectedTitle=6~45

9. Ashley S, Royle GT, Corder a, Herbert a, Guyer PB, Rubin CM, et al. Clinical, radiological and cytological diagnosis of breast cancer in young women. Br J Surg [Internet]. 1989;76(8):835–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2670059

10. Steinberg JL, Trudeau ME, Ryder DE, Chb MB, Fishell E, Chapman JW, et al. Combined Fine-Needle Aspiration, Physical Examination and Mammography in the Diagnosis of Palpable Breast Masses: Their Relation to Outcome for Women with Primary Breast Cancer. Cannadian J Surg. 1996;39.

11. Morris KT, Vetto JT, Petty JK, Lum SS, Schmidt WA, Toth-Fejel S, et al. A new score for the evaluation of palpable breast masses in women under age 40. Am J Surg. 2002;184(4):346–7.

12. Oken M, Creech R, Tormey D, Horton J, Davis T, McFadden E, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Vol. 5, American Journal of Clinical Oncology. 1982. p. 649–56.

13. West HJ (Jack), Jin JO. Performance Status in Patients With Cancer. JAMA Oncol [Internet]. 2015 Oct 1 [cited 2017 Jul 22];1(312):2015. Available from: http://oncology.jamanetwork.com/article.aspx?doi=10.1001/jamaoncol.2015.3113

14. Klein S. Evaluation of palpable breast masses. Am Fam Physician. 2005;71(9):1731–8.

15. Pawlaczyk A. An analysis of long term complications in breast cancer patients after conservative therapy. Reports Pract Oncol Radiother [Internet]. 2006;11(2):81–9. Available from: http://ac.els-cdn.com/S1507136706710525/1-s2.0-S1507136706710525-main.pdf?_tid=2a602c94-4c58-11e6-8e16-00000aacb35d&acdnat=1468785403_cef7ef1d1d9c9fcac99ca41c59e82f73

16. Bodai BI, Tuso P. Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. Perm J [Internet]. 2015;19(2):48–79. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25902343%5Cnhttp://www.ncbi.nlm.nih.gov/pubmed/25902343

17. NICE. Advanced breast cancer: diagnosis and treatment. National Institute for Health and Clinical Excellence Guideline 2009 [Internet]. Vol. 21, Clinical oncology (Royal College of Radiologists (Great Britain)). 2009. 365-367 p. Available from: http://www.nice.org.uk/nicemedia/live/11778/43414/43414.pdf

18. Carlson RW, Anderson BO, Burstein HJ, Carter WB, Edge SB, Farrar WB, et al. Invasive Breast Cancer Version 1.2016: Clinical Practice Guidelines in Oncology. JNCCN J Natl Compr Cancer Netw [Internet]. 2016;14(3):324–54. Available from: http://www.embase.com/search/results?subaction=viewrecord%7B&%7Dfrom=export%7B&%7Did=L46465551%7B%25%7D5Cnhttp://sfx.library.uu.nl/utrecht?sid=EMBASE%7B&%7Dissn=15401405%7B&%7Did=doi:%7B&%7Datitle=The+NCCN.+Invasive+breast+cancer%7B%25%7D3A+Clinical+pract

19. Morris KT. Usefulness of the Triple Test Score for Palpable Breast Masses. Arch Surg [Internet]. 2001;136(9):1008. Available from: http://archsurg.jamanetwork.com/article.aspx?doi=10.1001/archsurg.136.9.1008

Alomedika | Khusus untuk Dokter

Pendahuluan Kanker Payudara

Referensi

Artikel Terkait